{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:16:59Z","timestamp":1792264619993,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tips.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T20:25:33Z","timestamp":1749068733000},"page":"599-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["PSA inhibitors for contraception: insights from prostate cancer"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-8471","authenticated-orcid":false,"given":"Wipawee","family":"Winuthayanon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.05.005_bb0005","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","article-title":"Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019","volume":"8","author":"Bearak","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.tips.2025.05.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110438","article-title":"The demand for male contraception: Estimating the potential market for users of novel male contraceptive methods using United States National Survey of Family Growth data","volume":"135","author":"Nguyen","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.tips.2025.05.005_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmad008","article-title":"Advances in non-hormonal male contraception targeting sperm motility","volume":"29","author":"Mariani","year":"2023","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tips.2025.05.005_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/biolre\/ioaa076","article-title":"Preclinical contraceptive development for men and women","volume":"103","author":"Johnston","year":"2020","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tips.2025.05.005_bb0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.adf9341","article-title":"A brief history and future prospects of contraception","volume":"380","author":"Anderson","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.05.005_bb0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/GRF.0000000000000628","article-title":"Contraceptive technologies: looking ahead to new approaches to increase options for family planning","volume":"64","author":"HADDAD, L.B.","year":"2021","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.tips.2025.05.005_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/pharmrev.122.000787","article-title":"Nonhormonal male contraceptive development\u2014strategies for progress","volume":"76","author":"Nickels","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2025.05.005_bb0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51739","article-title":"A phenotypic screening platform utilising human spermatozoa identifies compounds with contraceptive activity","volume":"9","author":"Gruber","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.05.005_bb0045","article-title":"A screen of repurposed drugs identifies AMHR2\/MISR2 agonists as potential contraceptives","volume":"119","author":"Li","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","article-title":"Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future","volume":"19","author":"Van Poppel","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tips.2025.05.005_bb0055","doi-asserted-by":"crossref","first-page":"e198392","DOI":"10.1001\/jamanetworkopen.2019.8392","article-title":"The evolving paradigm of prostate cancer screening","volume":"2","author":"Albertsen","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tips.2025.05.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1071\/RD24002","article-title":"Exploring the impact of seminal anti-PSA antibodies on semen parameters: a comparative study","volume":"36","author":"Kumar","year":"2024","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.tips.2025.05.005_bb0065","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ijbiomac.2022.04.079","article-title":"Semenogelin, a coagulum macromolecule monitoring factor involved in the first step of fertilization: a prospective review","volume":"209","author":"Vickram","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tips.2025.05.005_bb0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/j.1939-4640.1995.tb00569.x","article-title":"Impaired secretory function of the prostate in men with oligo-asthenozoospermia","volume":"16","author":"Ahlgren","year":"1995","journal-title":"J. Androl."},{"key":"10.1016\/j.tips.2025.05.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10866-1","article-title":"Mutations in the prostate specific antigen (PSA\/KLK3) correlate with male infertility","volume":"7","author":"Gupta","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2025.05.005_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2741\/e800","article-title":"Presence of PSA antibodies in seminal plasma of infertile men","volume":"9","author":"Cuppett","year":"2017","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"10.1016\/j.tips.2025.05.005_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jri.2012.11.005","article-title":"Antibodies to prostate-specific antigen in immunoinfertile women and men","volume":"97","author":"Naz","year":"2013","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.tips.2025.05.005_bb0090","doi-asserted-by":"crossref","first-page":"716.e711","DOI":"10.1016\/j.ajog.2023.02.024","article-title":"ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study","volume":"228","author":"Thurman","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tips.2025.05.005_bb0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41467-023-36119-6","article-title":"On-demand male contraception via acute inhibition of soluble adenylyl cyclase","volume":"14","author":"Balbach","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.05.005_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/iub.2700","article-title":"The roles of proteases in prostate cancer","volume":"75","author":"Koistinen","year":"2023","journal-title":"IUBMB Life"},{"key":"10.1016\/j.tips.2025.05.005_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10555-019-09815-3","article-title":"Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment","volume":"38","author":"Moradi","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.tips.2025.05.005_bb0110","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.3390\/jcm12144791","article-title":"Non-hormonal contraception","volume":"12","author":"Howard","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tips.2025.05.005_bb0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/biolre\/ioaa075","article-title":"Mechanism of semen liquefaction and its potential for a novel non-hormonal contraception","volume":"103","author":"Anamthathmakula","year":"2020","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tips.2025.05.005_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40290-025-00555-0","article-title":"Contraception requirements in early clinical trials: considerations towards an evidence-based approach","volume":"39","author":"Dubich","year":"2025","journal-title":"Pharm. Med."},{"key":"10.1016\/j.tips.2025.05.005_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814035","article-title":"Non-canonical amino acids in analyses of protease structure and function","volume":"24","author":"Goettig","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pros.20773","article-title":"Novel small molecule inhibitors for prostate-specific antigen","volume":"68","author":"Koistinen","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.tips.2025.05.005_bb0135","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/acsmedchemlett.4c00257","article-title":"Synthesis and optimization of small molecule inhibitors of prostate specific antigen","volume":"15","author":"Erickson","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tips.2025.05.005_bb0140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.chembiol.2008.05.020","article-title":"Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen","volume":"15","author":"LeBeau","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2025.05.005_bb0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1515\/BC.2008.076","article-title":"Development of peptides specifically modulating the activity of KLK2 and KLK3","volume":"389","author":"Koistinen","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0150","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1021\/jm301718c","article-title":"Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors","volume":"56","author":"Kostova","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103478","article-title":"Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women","volume":"69","author":"Baldeon-Vaca","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.tips.2025.05.005_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107832118","article-title":"Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception","volume":"118","author":"Shrestha","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0165","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/biolre\/ioac023","article-title":"Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans","volume":"106","author":"Anamthathmakula","year":"2022","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tips.2025.05.005_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2407-13-195","article-title":"A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy","volume":"13","author":"Daniels-Wells","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tips.2025.05.005_bb0175","first-page":"893","article-title":"Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice","volume":"19","author":"Sinha","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tips.2025.05.005_bb0180","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00299-023-03028-3","article-title":"Co-transient expression of PSA-Fc and PAP-Fc fusion protein in plant as prostate cancer vaccine candidates and immune responses in mice","volume":"42","author":"Oh","year":"2023","journal-title":"Plant Cell Rep."},{"key":"10.1016\/j.tips.2025.05.005_bb0185","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bit.28029","article-title":"Biogenesis and mechanisms of microRNA-mediated gene regulation","volume":"119","author":"Rani","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tips.2025.05.005_bb0190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.tips.2025.05.005_bb0195","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1373\/clinchem.2018.295824","article-title":"MicroRNA-3162-5p-mediated crosstalk between kallikrein family members including prostate-specific antigen in prostate cancer","volume":"65","author":"Matin","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0200","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-10-1031","article-title":"miR-99 Family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation","volume":"71","author":"Sun","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2025.05.005_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/TUB-211568","article-title":"MicroRNA-99b-5p targets mTOR\/AR axis, induces autophagy and inhibits prostate cancer cell proliferation","volume":"44","author":"Niture","year":"2022","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tips.2025.05.005_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2021.08.078","article-title":"MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase C\u03b5 and correlated with poor prognosis in prostate cancer","volume":"576","author":"Liu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2025.05.005_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115612","article-title":"Doxorubicin prodrug-based nanomedicines for the treatment of cancer","volume":"258","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0220","article-title":"Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy","volume":"26","author":"Elsadek","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.tips.2025.05.005_bb0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.actbio.2021.12.019","article-title":"Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy","volume":"140","author":"Pereira","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.tips.2025.05.005_bb0230","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s00044-020-02572-x","article-title":"Synthesis and evaluation of new 4-peptidamido-2-fluorobenzyl phosphoramide mustard conjugates as prodrugs activated by prostate-specific antigen","volume":"29","author":"Aloysius","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.tips.2025.05.005_bb0235","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-023-38721-0","article-title":"Durable contraception in the female domestic cat using viral-vectored delivery of a feline anti-M\u00fcllerian hormone transgene","volume":"14","author":"Vansandt","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.05.005_bb0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41585-021-00431-x","article-title":"Considering the potential for gene-based therapy in prostate cancer","volume":"18","author":"Gregg","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tips.2025.05.005_bb0245","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41598-021-03324-6","article-title":"Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene","volume":"12","author":"Mizutani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2025.05.005_bb0250","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.adg8802","article-title":"Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells","volume":"380","author":"Rodr\u00edguez-Silvestre","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.05.005_bb0255","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/cells11030502","article-title":"Optimization of thymidine kinase-based safety switch for neural cell therapy","volume":"11","author":"Locatelli","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tips.2025.05.005_bb0260","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-5347(01)63094-5","article-title":"Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer","volume":"160","author":"Gotoh","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.tips.2025.05.005_bb0265","first-page":"4200","article-title":"The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts","volume":"59","author":"Yu","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2025.05.005_bb0270","first-page":"7464","article-title":"A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy","volume":"61","author":"DeWeese","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2025.05.005_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103325","article-title":"Evaluation of multi-epitope recombinant protein as a candidate for a contraceptive vaccine","volume":"145","author":"Mortazavi","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.tips.2025.05.005_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13535","article-title":"Zona pellucida glycoproteins: relevance in fertility and development of contraceptive vaccines","volume":"89","author":"Gupta","year":"2023","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.tips.2025.05.005_bb0285","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41585-023-00739-w","article-title":"Vaccines as treatments for prostate cancer","volume":"20","author":"Rastogi","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tips.2025.05.005_bb0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/2326-6066.CIR-13-0108","article-title":"Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer","volume":"2","author":"Gulley","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tips.2025.05.005_bb0295","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.18.02031","article-title":"Phase III trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer","volume":"37","author":"Gulley","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tips.2025.05.005_bb0300","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/oncolo\/oyad058","article-title":"Flutamide with or without PROSTVAC in non-metastatic castration resistant (M0) prostate cancer","volume":"28","author":"Madan","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.tips.2025.05.005_bb0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/pros.20135","article-title":"Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine","volume":"62","author":"Roos","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.tips.2025.05.005_bb0310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.cji.0000165353.19171.41","article-title":"Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer","volume":"28","author":"Miller","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.tips.2025.05.005_bb0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41557-021-00877-x","article-title":"Strategies for developing DNA-encoded libraries beyond binding assays","volume":"14","author":"Huang","year":"2022","journal-title":"Nat. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0320","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.adl2688","article-title":"Reversible male contraception by targeted inhibition of serine\/threonine kinase 33","volume":"384","author":"Ku","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.05.005_bb0325","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.adp6432","article-title":"An emerging target for male contraception","volume":"384","author":"Holdaway","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.05.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322934121","article-title":"Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology","volume":"121","author":"Madasu","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0335","doi-asserted-by":"crossref","first-page":"16782","DOI":"10.1073\/pnas.2005447117","article-title":"Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library","volume":"117","author":"Dawadi","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0340","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111172118","article-title":"DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors","volume":"118","author":"Chamakuri","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s42004-023-00961-y","article-title":"DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors","volume":"6","author":"Jimmidi","year":"2023","journal-title":"Commun. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0350","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1021\/acscombsci.8b00116","article-title":"Quantitative comparison of enrichment from DNA-encoded chemical library selections","volume":"21","author":"Faver","year":"2019","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.tips.2025.05.005_bb0355","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/hsz-2020-0377","article-title":"Antibody display technologies: selecting the cream of the crop","volume":"403","author":"Valldorf","year":"2022","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tips.2025.05.005_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.794742","article-title":"Yeast surface display system: strategies for improvement and biotechnological applications","volume":"9","author":"Teymennet-Ram\u00edrez","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tips.2025.05.005_bb0365","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijbiomac.2022.03.113","article-title":"An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages","volume":"208","author":"Mahdavi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tips.2025.05.005_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/OAJC.S375634","article-title":"A brief history and advancement of contraceptive multipurpose prevention technology (cMPT) products","volume":"14","author":"Dohadwala","year":"2023","journal-title":"Open Access J. Contracept."},{"key":"10.1016\/j.tips.2025.05.005_bb0375","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2022.36.S1.R5942","article-title":"Functional analysis of KLK3\/PSA protease activity in primates","volume":"36","author":"Kahveci","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2025.05.005_bb0380","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/evolut\/qpaf012","article-title":"Comparative functional analyses of the prostate-specific KLK3 enzyme in primates reveal the impact of sexual selection","volume":"79","author":"Kahveci","year":"2025","journal-title":"Evolution"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:07:48Z","timestamp":1751580468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0165614725000951"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.05.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSA inhibitors for contraception: insights from prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}